Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1871, Issue 1, Pages 20-28Publisher
ELSEVIER
DOI: 10.1016/j.bbcan.2018.10.001
Keywords
Cancer; Drug resistance; Nervous systems; Neural signals; Immunotherapy
Categories
Funding
- National Natural Science Foundation of China [81773086, 81773258, 81572845, 31370825, 81402562]
- Jiangsu Natural Science Foundation [BK20171161]
- Key University Science Research Project of Jiangsu Province [17KJA320009]
- Key Research & Developement Plan of Jiangsu Province [BE2018634]
- Key young talents in medicine of Jiangsu Province [QNRC2016803]
- Jiangsu Province Innovation and Entrepreneurship Talents Project
Ask authors/readers for more resources
The treatment of cancer has made great progress. However, drug resistance remains problematic. Multiple physiologic processes of tumor development can be dominated by central and sympathetic nervous systems. The interactions between the nervous system, immune system, and tumor occur consistently and dynamically. Recent evidence suggests that nerves and neural signals are intimately involved in the development of resistance to cancer therapies. In this review, we will provide an overview of the recent progress in this rapidly growing area and discuss the potential new strategies for targeting the neural signaling pathway to improve the effectiveness of chemotherapies, targeted therapies, and immunotherapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available